Abstract:
Background: Diet is a key component in the disease susceptibility of individuals. Reducing inflammation especially in people with inflammatory disorders is thought to decrease disease susceptibility. The aim of this trial was to investigate the effects of a dietary supplement which contains Vitamin D, Omega 3, Co-enzyme Q10, Zeaxanthin, Lutein and Astaxanthion inflammatory markers in healthy people. Methods: The cross over trial was double blinded, randomised and placebo controlled. The study population (n = 30) was recruited from Auckland, New Zealand. The intervention or placebo was for 28 days, followed by a washout of 28 days followed by the placebo or intervention for 28 days. In this preliminary analysis blood samples were measured for C-Reactive protein (CRP), HDL, LDL, Triglycerides and cholesterol levels. A quality of life questionnaire, height and weight were also assessed. Results: Analysis of these measures found significant differences between the intervention and placebo groups for CRP (p < 0.0288) HDL (p < 0.0019) and triglycerides (p < 0.0091). Conclusion: In this preliminary analysis the supplement was shown to be effective in reducing key inflammatory markers in healthy people.
